Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Smolen

Showing results (1221-1230 of 1,467) with videos related to

Pageof 147
Sort By:
Annals of the Rheumatic Diseases|February 11, 2025
Safety of Janus kinase inhibitors in immune-mediated inflammatory diseases - a systematic literature review informing the 2024 update of an international expert consensus statementVictoria Konzett, Josef S Smolen, Peter Nash, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 26, 2019
FOXO3 is involved in the tumor necrosis factor-driven inflammatory response in fibroblast-like synoviocytesBernhard Brandstetter, Karolina Dalwigk, Alexander Platzer, et al.
Annals of the Rheumatic Diseases|December 10, 2023
Bona fide dendritic cells are pivotal precursors for osteoclastsAntonia Puchner, Elisabeth Simader, Victoria Saferding, et al.
Arthritis and Rheumatism|November 6, 2004
Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trialE William St Clair, Désirée M F M van der Heijde, Josef S Smolen, et al.
Arthritis and Rheumatism|March 2, 2006
Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trialJosef S Smolen, Désirée M F M Van Der Heijde, E William St Clair, et al.
Plos One|March 4, 2016
Depression, Stressful Life Events, and the Impact of Variation in the Serotonin Transporter: Findings from the National Longitudinal Study of Adolescent to Adult Health (Add Health)Brett C Haberstick, Jason D Boardman, Brandon Wagner, et al.
Annals of the Rheumatic Diseases|September 28, 2016
Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: a phase II dose-ranging randomised controlled trialDaniel J Wallace, Vibeke Strand, Joan T Merrill, et al.
Annals of the Rheumatic Diseases|April 18, 2002
Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjögren's syndrome (pSS): a European multicentre studyA G Tzioufas, R Wassmuth, U G Dafni, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 10, 2024
Examining the Impact of Structural Uncertainty Across 10 Type 2 Diabetes Models: Results From the 2022 Mount Hood ChallengeJames Altunkaya, Xinyu Li, Amanda Adler, et al.
The New England Journal of Medicine|March 31, 2016
Baricitinib in Patients with Refractory Rheumatoid ArthritisMark C Genovese, Joel Kremer, Omid Zamani, et al.
Pageof 147

Showing results (1221-1230 of 1,467) with videos related to

Sort By:
Pageof 147
Annals of the Rheumatic Diseases|February 11, 2025
Safety of Janus kinase inhibitors in immune-mediated inflammatory diseases - a systematic literature review informing the 2024 update of an international expert consensus statementVictoria Konzett, Josef S Smolen, Peter Nash, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 26, 2019
FOXO3 is involved in the tumor necrosis factor-driven inflammatory response in fibroblast-like synoviocytesBernhard Brandstetter, Karolina Dalwigk, Alexander Platzer, et al.
Annals of the Rheumatic Diseases|December 10, 2023
Bona fide dendritic cells are pivotal precursors for osteoclastsAntonia Puchner, Elisabeth Simader, Victoria Saferding, et al.
Arthritis and Rheumatism|November 6, 2004
Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trialE William St Clair, Désirée M F M van der Heijde, Josef S Smolen, et al.
Arthritis and Rheumatism|March 2, 2006
Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trialJosef S Smolen, Désirée M F M Van Der Heijde, E William St Clair, et al.
Plos One|March 4, 2016
Depression, Stressful Life Events, and the Impact of Variation in the Serotonin Transporter: Findings from the National Longitudinal Study of Adolescent to Adult Health (Add Health)Brett C Haberstick, Jason D Boardman, Brandon Wagner, et al.
Annals of the Rheumatic Diseases|September 28, 2016
Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: a phase II dose-ranging randomised controlled trialDaniel J Wallace, Vibeke Strand, Joan T Merrill, et al.
Annals of the Rheumatic Diseases|April 18, 2002
Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjögren's syndrome (pSS): a European multicentre studyA G Tzioufas, R Wassmuth, U G Dafni, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 10, 2024
Examining the Impact of Structural Uncertainty Across 10 Type 2 Diabetes Models: Results From the 2022 Mount Hood ChallengeJames Altunkaya, Xinyu Li, Amanda Adler, et al.
The New England Journal of Medicine|March 31, 2016
Baricitinib in Patients with Refractory Rheumatoid ArthritisMark C Genovese, Joel Kremer, Omid Zamani, et al.
Pageof 147